January 2024 in “Bulletin of Medical Science” In this study of 93 patients, adding pantohematogen to a treatment regimen for androgenetic alopecia led to greater improvements in scalp microcirculation, psychoemotional status, hemoglobin levels, and hair restoration compared to a group receiving scalp physiotherapy.
178 citations
,
April 2017 in “Journal of The American Academy of Dermatology” This systematic review and meta-analysis found that minoxidil, finasteride, and low-level laser light therapy significantly improve hair growth in men with androgenetic alopecia, while minoxidil is also effective for women, compared to placebo.
15 citations
,
January 2014 in “Hair therapy & transplantation” This study found that treatment with platelet-rich plasma showed some hair re-growth in patients with severe alopecia areata, but results were not sustained and treatment was associated with pain and discomfort.
1 citations
,
January 2014 in “Hair therapy & transplantation” This review discusses various treatment options for Alopecia Areata, focusing on both medical and psychological approaches, and reports no new clinical results.
June 2025 in “Indus journal of bioscience research.” This study conducted at the Pakistan Emirates Military Hospital found that microneedling combined with topical triamcinolone acetonide was significantly more effective and well-tolerated than microneedling alone for treating localized alopecia areata, with 60% of participants achieving complete recovery compared to 5% in the microneedling-only group.
May 2025 in “Journal of Photochemistry and Photobiology B Biology” In this study, researchers observed that blue LED irradiation enhanced cosmetic permeation, increased diameter, and improved resistance of hair fiber in Caucasian and Asian ethnic groups, whereas African hair showed less change.
August 2024 in “Aesthetic Plastic Surgery” In this study, injecting foreskin-derived mesenchymal stromal cell exosomes into the scalps of men with androgenetic alopecia significantly increased hair density and patient satisfaction without side effects over a 12-week period.
This study found that cyproterone compound is not more effective than oral isotretinoin in treating nodulocystic acne in adult females with SAHA syndrome or cutaneous hyperandrogenism, suggesting isotretinoin may be preferable due to its established effectiveness in reducing acne lesions.
April 2016 in “Journal of The American Academy of Dermatology” Different treatments are effective for hair loss conditions, but results vary by individual factors.
May 2015 in “Journal of The American Academy of Dermatology” Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.
2 citations
,
June 2025 in “Cosmetics” This study observed that a five-week topical treatment with cold-pressed Rosa canina seed oil significantly reduced mean wrinkle scores and UV-induced spots in volunteers, suggesting potential anti-aging and photoprotective benefits attributed to its high carotenoid content.
November 2023 in “Journal of Cosmetic Dermatology” In this study, tofacitinib treatment significantly reduced hair loss on the head and body, as well as nail involvement, in patients with alopecia areata over 18 months, with minimal side effects reported.
This study reports that the proposed treatment scheme for diffuse and androgenetic hair loss showed high therapeutic efficacy in improving patients' hair condition.
9 citations
,
January 2015 in “Laboratory Animal Research” This study found that oral administration of Laminaria japonica and Cistanche tubulosa extracts may improve hair regrowth in mice, comparable to the effects of 3% Minoxidil, potentially due to their anti-inflammatory properties.
1 citations
,
June 2024 in “JMIR Dermatology” This study found that 675 nm laser treatment improved androgenetic alopecia in Indian patients, resulting in significant increases in hair count, density, and thickness after 14 sessions, enhancing the anagen phase and other hair-related parameters.
1 citations
,
January 2020 in “Aston Publications Explorer (Aston University)” This research found that physical activity may modestly improve insulin resistance, lipids, and fitness in women with PCOS, though the evidence remains weak and more robust studies are needed.
August 2026 in “Journal of Maxillofacial and Oral Surgery” This study investigated treatments for male androgenetic alopecia, finding that combining injectable platelet-rich fibrin (i-PRF) with microneedling increased hair growth more effectively than i-PRF alone according to questionnaires and photographic assessments.
January 2025 in “Dermatologic Therapy” In this study, the combination of topical minoxidil and betamethasone was found to be more effective for hair regrowth and patient satisfaction in alopecia areata patients compared to betamethasone alone or with herbal oils, though further randomized trials are recommended.
July 2024 in “Medical alphabet” This study observed that intradermal injections of Betamethasone were more effective than topical Clobetazole for treating alopecia areata in children, while Tofacitinib showed higher efficacy in those with atopic dermatitis.
December 2023 in “Farmateka” Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.
September 2023 in “Dermatology and Therapy” In a Belgian cohort study, nearly 90% of alopecia areata patients treated with oral baricitinib experienced hair regrowth, with more than 70% achieving a favorable SALT score, particularly in patchy cases, though some relapsed post-treatment. No serious adverse events were noted.
June 2023 in “Seven Editora eBooks” This integrative review concluded that microneedling therapy may be an effective and safe treatment for hair disorders like androgenetic alopecia, alopecia areata, and telogen effluvium, particularly when exacerbated by SARS-CoV-2 infection, offering promising results compared to other therapies.
10 citations
,
December 2024 in “Allergy” This study found that tralokinumab effectively reduced the severity of moderate-to-severe atopic dermatitis over 28 weeks in adults, with significant improvements in clinical outcomes and biological markers, although 27.4% of patients discontinued treatment due to adverse events or ineffectiveness.
4 citations
,
January 2019 in “Open Access Macedonian Journal of Medical Sciences” In this study, oral mini-pulse methylprednisolone therapy for alopecia areata was reported to be effective and safe over 6 months, with 82.2% of patients recovering well and no adverse events observed.
2 citations
,
January 2019 in “The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology” Korean medical treatments are effective for alopecia areata, especially in less severe cases.
2 citations
,
September 1989 in “PubMed” This study found that canrenone significantly reduced hair growth and decreased certain androgen levels in women with idiopathic post-puberal hirsutism, suggesting potential effectiveness as a treatment.
1 citations
,
April 2026 in “Aesthetic Plastic Surgery” This study found that radiofrequency microneedling is effective and well-tolerated for improving various skin conditions, showing comparable efficacy to fractional lasers for atrophic acne scars with generally favorable patient satisfaction and safety.
July 2026 in “International Journal of Drug Delivery Technology” This review of non-surgical treatments for androgenetic alopecia reports that combination therapies, particularly platelet-rich plasma with low-level laser therapy, tend to be more effective than using each treatment alone.
April 2026 in “Buletin Veteriner Udayana” In this case report, researchers observed that apple cider vinegar used as a topical antimicrobial agent effectively improved skin condition and reduced lesions associated with scabiosis and malasseziosis in a 3-year-old domestic cat, with noticeable results in 7 days.
March 2026 in “The Journal of Dermatology” This study found that ritlecitinib 50 mg is cost-effective compared to no treatment for patients in Japan with alopecia areata and significant scalp hair loss, demonstrating an incremental cost-effectiveness ratio below the country's cost-effectiveness threshold.